MicroPort CardioFlow Medtech

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (hereafter referred to as MicroPort CardioFlow) was established in 2015, located in Zhangjiang High-Tech Park, Shanghai, it’s one of the holding subsidiaries of MicroPort Group.

MicroPort CardioFlow is dedicated in providing advanced minimally invasive therapies for structural heart diseases, with best-in-class R&D, manufacturing, marketing, and technical consulting capacities. MicroPort CardioFlow developed the VitaFlow Transcatheter Aortic Valve System, it’s granted with NMPA (National Medical Products Administration) approval for commercialization.